Related by context. All words. (Click for frequent words.) 72 myocardial infarction MI 72 cerebrovascular events 71 reinfarction 71 thrombotic events 70 arterial thromboembolic events 70 infarctions 70 nonfatal MI 69 hemorrhagic strokes 69 acute myocardial infarction AMI 69 ipsilateral stroke 69 sustained ventricular tachycardia 69 TEAEs 69 noncardiac 68 definite stent thrombosis 68 MIs 68 repeat revascularization 68 thromboembolic events 68 β blockers 68 systolic dysfunction 68 cerebrovascular accidents 68 myocardial infarction 68 recurrent ischemia 68 cardioembolic stroke 68 revascularization procedures 67 acute myocardial infarctions 67 reoperations 67 beta blocker therapy 67 recurrent VTE 67 MACCE 67 Stent thrombosis 67 thromboembolism 67 silent ischemia 67 coronary revascularization 67 rebleeding 67 Erythropoietic therapies may 67 upper gastrointestinal bleeding 66 stent thromboses 66 nondiabetic patients 66 myocardial infarctions MIs 66 microbleeds 66 severe exacerbations 66 thromboembolic 66 VT VF 66 revascularizations 66 intracranial bleeding 66 unstable angina 66 intracerebral hemorrhage 66 lacunar 66 NATRECOR R 66 cardiac dysfunction 66 carotid stenosis 66 myocardial infarction stroke 66 onset atrial fibrillation 66 LV dysfunction 66 Postoperative complications 66 symptomatic VTE 65 periprocedural 65 thromboembolic complications 65 intracerebral hemorrhages 65 ischemic strokes 65 ST elevation myocardial 65 macrovascular events 65 ischemic complications 65 postoperative complication 65 cardiovascular hospitalizations 65 morphometric vertebral fractures 65 myocardial infarctions MI 65 ventricular arrhythmia 65 underwent CABG 65 ventricular tachyarrhythmia 65 recurrent myocardial infarction 65 cerebral infarction 65 infarction STEMI 65 infarcts 65 nonfatal stroke 65 stroke transient ischemic 65 intracerebral haemorrhage 65 perioperative complications 64 subarachnoid hemorrhages 64 perioperative mortality 64 carotid artery blockage 64 ischemic cardiomyopathy 64 intravenous bisphosphonates 64 unstable angina pectoris 64 STEMIs 64 CVD mortality 64 thrombotic complications 64 unstable angina UA 64 postoperative AF 64 carotid plaque 64 hemorrhagic complications 64 antiplatelet drugs 64 NYHA Class II 64 left ventricular dysfunction 64 patients undergoing CABG 64 neurologic complications 64 nonfatal myocardial infarction MI 64 subclinical hypothyroidism 64 syncopal 64 rFVIIa 64 VADT 64 renal dysfunction 64 extrapyramidal symptoms 64 hypoglycemic episodes 64 tachyarrhythmias 64 atherothrombotic disease 64 coronary blockages 64 recurrent venous thromboembolism 63 decompensated heart failure 63 nonischemic 63 advanced adenomas 63 ejection fractions 63 microvascular disease 63 acute myocardial infarction MI 63 haemorrhagic stroke 63 ruptured aneurysms 63 ximelagatran 63 prolonged QT interval 63 colorectal adenoma 63 non valvular atrial 63 rhythm disturbances 63 recurrent DVT 63 elevated triglyceride levels 63 Hypotension 63 acute myocardial infarction 63 de ath 63 enzyme elevations 63 undergoing CABG 63 NATRECOR ® 63 macrovascular disease 63 ACUITY trial 63 glycated hemoglobin levels 63 recurrent ischemic stroke 63 thrombolytic agents 63 cerebral microbleeds 63 advanced adenoma 63 liver transplant recipients 63 nonfatal myocardial infarction 63 cryptogenic stroke 63 nonvertebral fractures 63 fatal myocardial infarction 63 resuscitated cardiac arrest 63 cardiovascular hospitalization 63 hyperkalemia 63 multivessel disease 63 discontinuations due 63 deep venous thromboses 63 ventricular fibrillation VF 63 severe hypoglycemic 63 vertebral fracture 63 oral hypoglycemic agents 63 ICD implantation 63 Torsades de Pointes 62 MGUS 62 antiplatelet medications 62 valvular disease 62 intensive statin therapy 62 transient ischemic attacks 62 eplerenone 62 stable angina 62 ICD shocks 62 TAVR 62 binary restenosis 62 coronary interventions 62 locoregional recurrence 62 acute aortic dissection 62 endometrial hyperplasia 62 infarction NSTEMI 62 fluvastatin 62 intraoperative complications 62 angina chest 62 intima media thickness 62 macroalbuminuria 62 nondiabetics 62 cardiovascular mortality 62 paroxysmal AF 62 noncardiovascular 62 asymptomatic PAD 62 coronary stenosis 62 ALT flares 62 postoperative complications 62 deep vein thromboses 62 aldosterone antagonist 62 hyperacute 62 PRADAXA #mg 62 ECG abnormalities 62 hepatorenal syndrome 62 ventricular tachycardia VT 62 troponin T 62 tolvaptan 62 Febrile neutropenia 62 pericardial effusions 62 postoperative mortality 62 cerebral infarctions 62 revascularization procedure 62 NSTEMI 62 cardiogenic shock 62 endometrial carcinoma 62 ocular adverse 62 inhospital 62 acute coronary 62 ticagrelor 62 angina pectoris 62 noncardiac surgery 62 LVSD 62 undergoing coronary artery 62 MI myocardial infarction 62 ischemic lesions 62 composite endpoint 62 torsades de pointes 62 systolic hypertension 62 hypoglycemic events 62 ADHF 62 antithrombotic therapies 62 thrombolytic therapy 61 CHD mortality 61 prostate cancer CaP 61 splenectomized patients 61 CHD CVD 61 periprocedural MI 61 myocardial ischemia 61 autonomic dysfunction 61 XIENCE V PROMUS Stent 61 malignant neoplasm 61 systemic embolism 61 vertebral fractures 61 infective endocarditis 61 laboratory abnormalities 61 acute coronary syndrome 61 adenomatous polyps 61 white matter hyperintensities 61 acute coronary syndromes ACS 61 reperfusion therapy 61 HF hospitalization 61 acute coronary syndromes 61 preserved ejection fraction 61 typical antipsychotics 61 pericardial effusion 61 NYHA Class III 61 ARCOXIA 61 recurrent coronary 61 neutrophil counts 61 sirolimus stent 61 HbA 1c levels 61 ATACAND 61 preoperative chemotherapy 61 LVEF 61 antiarrhythmic drug 61 coronary revascularization procedures 61 paclitaxel eluting stents 61 UA NSTEMI 61 postoperative infections 61 refractory ischemia 61 Myocardial infarction 61 cerebrovascular accident 61 bivalirudin 61 ICD implants 61 thromboses 61 events MACE 61 ICDs implanted 61 oral antidiabetic medication 61 KRAS mutations occur 61 lipid lowering medications 61 TNF antagonist 61 lipid lowering drugs 61 subarachnoid haemorrhage 61 microalbuminuria 61 microvascular complications 61 haemorrhagic strokes 61 proximal DVT 61 angiotensin converting enzyme inhibitors 61 aspirin clopidogrel 61 Events MACE 61 sternal wound infections 61 Cognitive impairment 61 MADIT II 61 venous thromboembolisms 61 CABG coronary artery 61 torsade de pointes 61 psychiatric comorbidities 61 severe neutropenia 61 ARVD 61 ischemic cardiovascular 61 nonselective NSAIDs 61 target vessel revascularization 61 cardiac resynchronization 61 hematologic toxicity 61 underwent coronary angiography 61 atypical hyperplasia 60 NSTE ACS 60 STEMI patients 60 alteplase 60 ischemic stroke 60 asthma exacerbation 60 severe mitral regurgitation 60 atrial arrhythmias 60 thrombocytopenic 60 GP IIb IIIa inhibitors 60 thyrotoxicosis 60 coronary intervention 60 diastolic heart 60 lipid lowering therapy 60 postprocedure 60 nonvertebral fracture 60 ABCB1 60 carotid IMT 60 aneurysmal subarachnoid hemorrhage 60 ezetimibe simvastatin 60 neurodevelopmental impairment 60 nontraumatic 60 cryptogenic 60 glycoprotein IIb IIIa inhibitors 60 endophthalmitis 60 advanced neoplasia 60 TMP SMX 60 Complication rates 60 hepatectomy 60 generalized edema 60 CYPHER Stent 60 atherothrombosis 60 cTnT 60 carotid plaques 60 receiving prophylactic anticoagulation 60 arterial occlusion 60 underwent angiography 60 Avandia Actos 60 afib 60 SLNB 60 hemoglobin A1c levels 60 tirofiban 60 gastrointestinal perforation 60 reintervention 60 adrenal insufficiency 60 neurological abnormalities 60 postoperative morbidity 60 endarterectomy 60 pulmonary toxicity 60 hypoperfusion 60 colorectal liver metastases 60 EXJADE 60 postoperative atrial fibrillation 60 NYHA class 60 infarct size 60 QT prolongation 60 comorbid conditions 60 Adjuvant chemotherapy 60 coronary artery blockages 60 severe hypoglycemia 60 gouty arthritis 60 concomitant medications 60 ertapenem 60 patients undergoing percutaneous 60 renal insufficiency 60 Renal impairment 60 fasting glucose levels 60 catheter angiography 60 nonmelanoma skin cancers 60 lumiracoxib 60 sotalol 60 ischemia driven 60 lipid lowering agents 60 non aspirin NSAIDs 60 circulating EPCs 60 QT interval prolongation 60 recurrent glioblastoma multiforme 60 streptokinase 60 ventricular tachyarrhythmias 60 perioperatively 60 osteoporotic vertebral compression fractures 60 virologic failure 60 macrovascular 60 ventricular arrhythmias 60 poor metabolizers 60 symptomatic carotid stenosis 60 cytopenias 60 underwent resection 60 rosuvastatin #mg 60 Hemorrhagic stroke 60 TAXUS Express Stent 60 PASI scores 60 Subgroup analyzes 60 NYHA functional class 60 unfractionated heparin 60 chlorthalidone 60 coronary artery bypass grafts 60 atherogenic dyslipidemia 60 anticoagulant warfarin 60 subclinical hyperthyroidism 60 HbA 1c 60 cardiac tamponade 60 brain metastases 60 revascularisation 60 FluCAM arm 60 aminotransferases 60 IIIa inhibitor 60 wound dehiscence 60 stenoses 60 prescribed statins 60 nesiritide 60 benazepril 60 cTnT levels 60 events TEAEs 60 CTEPH 60 acute STEMI 60 nadroparin 60 DES implantation 60 osteosarcomas 60 pCR 60 antiplatelet medication 59 fibrinolytic 59 invasive fungal infection 59 graft occlusion 59 paricalcitol 59 oxycodone CR 59 VTEs 59 nonsignificant 59 VIIBRYD 59 cardioembolic 59 hyperglycaemia 59 ticlopidine 59 segment elevation myocardial 59 skeletal metastases 59 adrenalectomy 59 events SAEs 59 nonfatal cardiovascular 59 heparin induced thrombocytopenia 59 QTc prolongation 59 VaD 59 NIHSS 59 venous thrombotic events 59 confirmed thrombotic cardiovascular 59 ß blockers 59 Venous thromboembolism 59 recanalization 59 intracranial hemorrhage ICH 59 Hemorrhagic strokes 59 angioplasties stents 59 salmeterol HFA MDI 59 thromboprophylaxis 59 post thrombotic syndrome 59 symptomatic intracranial 59 neuropsychiatric symptoms 59 VTE prophylaxis 59 cerebral vasospasm 59 renal cell carcinomas 59 atheroma volume 59 artery stenosis 59 IPAH 59 PLX STROKE targeting 59 angiographic outcomes 59 pulmonary emboli 59 gastrointestinal bleeds 59 myocardial fibrosis 59 bacteriuria 59 glitazones 59 thyrotropin levels 59 SORT OUT III 59 fragility fractures 59 dobutamine 59 serum creatinine levels 59 stent thrombosis 59 Ischemic strokes 59 unstable angina chest 59 artery reclogging 59 PRADAXA 59 Serious adverse reactions 59 adenoma 59 antiplatelet agents 59 silent myocardial ischemia 59 overlapping stents 59 nadolol 59 platelet reactivity 59 radiographic findings 59 variceal bleeding 59 MADRS score 59 Treatment emergent adverse 59 vasospasm 59 revascularization 59 loop diuretics 59 serous ovarian cancer 59 ruboxistaurin 59 noncardiovascular mortality 59 acute decompensation 59 dopaminergic therapy 59 undergoing coronary angiography 59 COPD exacerbations 59 coronary atherosclerosis 59 colorectal adenomas 59 recurrent atrial fibrillation 59 incomplete revascularization 59 stratifying patients 59 Thrombotic events 59 left ventricular systolic 59 abnormal mammograms 59 venous thrombosis 59 NNRTI resistance 59 #mmHg [001] 59 proliferative diabetic retinopathy 59 coinfected patients 59 Thrombolysis 59 diastolic hypertension 59 prostate TURP 59 transient ischemic attack 59 asymptomatic carotid stenosis 59 cardiovascular morbidity 59 subgroup analyzes 59 hsCRP levels 59 thiazide diuretics 59 aldosterone antagonists 59 mcg kg REBETOL 59 carotid artery stenosis 59 vasovagal syncope 59 conventional angiography 59 asthma exacerbations 59 atherosclerotic disease 59 elevated triglycerides 59 TAXUS stent 59 diastolic blood pressures 59 acute cholecystitis 59 malignant neoplasms 59 achieved ACR# 59 angiotensin receptor blockers ARBs 59 antithrombotic therapy 59 syncope fainting 59 neurologic symptoms 58 intravitreal injections 58 HSCT 58 discontinuations 58 intraventricular hemorrhage 58 hypoxemia 58 percutaneous coronary interventions 58 candesartan 58 necrotizing pancreatitis 58 nonischemic cardiomyopathy 58 nicardipine 58 XIENCE V demonstrated 58 elective PCI 58 invasive aspergillosis 58 hip BMD 58 Thal Dex 58 mL/min/#.# m 2 58 subtrochanteric 58 receiving VELCADE 58 ExTRACT TIMI 58 induce orthostatic hypotension 58 nonfatal heart 58 lobular breast cancer 58 renal artery stenosis 58 CCyR 58 coronary artery stenosis 58 recurrent stroke 58 anastomotic leak 58 dalteparin 58 enalapril 58 IgA deficiency 58 T2 lesions 58 pamidronate 58 postoperative delirium 58 cerebral vascular 58 dysglycemia 58 transaminase elevations 58 NIH CPSI 58 serum calcium levels 58 TRITON TIMI 58 urgent coronary revascularization 58 resynchronization therapy 58 lower extremity amputation 58 timepoints 58 certolizumab 58 fibrinolytic therapy 58 venlafaxine Effexor 58 severe hypersensitivity reactions 58 intraocular inflammation 58 bezafibrate 58 superficial vein thrombosis 58 congenital abnormalities 58 anemia neutropenia 58 femoral shaft fractures 58 chorioamnionitis 58 mcg QD 58 warfarin therapy 58 hypercalcemia 58 macrovascular complications 58 arterial calcification 58 serum aminotransferase levels 58 familial AF 58 cilostazol 58 oral antidiabetic drugs 58 OSAHS 58 aortic insufficiency 58 HAM D# scores 58 COREG 58 enoxaparin 58 hippocampal atrophy 58 Severe hypoglycemia 58 kidney transplant recipients 58 Ischemic stroke 58 myocardial infraction 58 receiving VICTRELIS 58 atypical fractures 58 carcinoids 58 salpingo oophorectomy 58 tenecteplase 58 octreotide LAR 58 gastric cardia 58 nonfasting triglyceride levels 58 carotid endarterectomy 58 fragility fracture 58 elevated troponin 58 urolithiasis 58 intracranial atherosclerosis 58 non squamous NSCLC 58 clinically insignificant 58 paroxetine Paxil 58 aspirin heparin 58 treat NNT 58 sirolimus eluting stents 58 pulmonary embolism PE 58 glomerular filtration 58 pathologic fractures 58 adverse cytogenetics 58 carcinoid tumors 58 coronary artery disease 58 hypophosphatemia 58 levosimendan 58 contrast induced nephropathy 58 polyp recurrence 58 statistically nonsignificant 58 hypoglycaemic episodes 58 ventricular remodeling 58 elevated LDL cholesterol 58 vaccinees 58 estimated glomerular filtration 58 SAEs 58 artery calcification 58 inflammatory biomarkers 58 variant angina 58 gout flares 58 GnRH agonists 58 left ventricular hypertrophy 58 squamous cell lung cancer 58 grade gliomas 58 thyroid nodules 58 PCIs 58 nonrandomized 58 nonalcoholic steatohepatitis 58 hypertensives 58 CABG surgeries 58 gastrointestinal perforations 58 cerebral ischemia 58 simvastatin ezetimibe 58 intra abdominal abscess 58 dexrazoxane 58 lymphocytosis 58 death reinfarction 58 CMV infection 58 Carotid Revascularization Endarterectomy vs. 58 intracranial stenosis 58 hypokalemia 58 hematologic adverse 58 postoperative hemorrhage 58 slow metabolizers 58 PCNSL 58 unknown etiology 58 nonmelanoma skin cancer 58 pyelonephritis 58 overt hypothyroidism 58 tumor recurrence 58 rhythm abnormalities 58 androgen deprivation 58 intravenous diuretics 58 pheochromocytoma 58 NNT = 58 renal impairment 58 differentiated thyroid 58 TAXUS Stent 58 corticosteroid therapy 58 TAXUS p value 58 biochemical recurrence 58 uncontrolled hypertension 58 aortic valve stenosis 58 thrombophilia 58 preterm deliveries 58 Unstable Angina 58 rt PA 58 haematologic 58 nonoperative treatment 58 varicella infection 58 myopathy rhabdomyolysis 58 renal cysts 58 atypical ductal hyperplasia 58 flutamide 58 ventricular tachycardia 58 BARACLUDE ® 58 STEMI 58 intracerebral 58 patent foramen ovale 58 stent implantation 58 CC genotype 58 doxorubicin docetaxel 58 PSADT 58 primidone 58 Intracerebral hemorrhage 58 CYPHER ® 58 leiomyomas 58 fibrinolysis 58 cardiac biomarkers 58 artery blockages 58 cervical spine fractures 58 clot busting therapy 58 hemodynamic instability 58 tumor lysis syndrome 58 interstitial pneumonia 58 arterial thrombotic 58 uncoated stents 58 beta blockers ACE inhibitors 58 inhaled glucocorticoids 58 thrombus aspiration 58 leucopenia 58 narrowings 58 Nesiritide 58 Genous stent 58 colorectal neoplasia 58 renal toxicity 57 target lesion revascularizations 57 cardiomegaly 57 bypass grafting 57 fluid overload 57 beta carotene supplementation 57 HIV HCV coinfected 57 elevated ALT 57 colorectal neoplasms 57 prodromal symptoms 57 ventricular dysfunction 57 A1c levels 57 angiographically 57 coronary insufficiency 57 CP CPPS 57 symptomatic hypotension 57 cytogenetic abnormalities 57 cerebrovascular disease 57 antihypertensive therapy 57 pulmonary capillary wedge 57 revascularisation procedures 57 atrioventricular block 57 pulmonary embolisms 57 severe hypoglycaemia 57 valsartan 57 Acute Coronary Syndromes ACS 57 carotid intima media 57 left ventricular ejection 57 arrhythmias 57 hyperbilirubinemia 57 haloperidol Haldol 57 onset seizures 57 microemboli 57 prednisone prednisolone 57 pacemaker implantation 57 endometrial thickness 57 Y BOCS 57 Arch Intern Med 57 REYATAZ r arm 57 symptomatic intracerebral hemorrhage 57 colectomy 57 T1DM 57 intravesical therapy 57 target lesion revascularization 57 T2DM 57 venous thromboembolism 57 Ventricular tachycardia 57 HbA1C levels 57 perfusion defects 57 bronchogenic carcinoma 57 vaso occlusive crisis 57 Uncontrolled hypertension 57 anticlotting drugs 57 intracerebral hemorrhage ICH 57 hypercholesterolemic patients 57 mesotheliomas 57 CABG surgery 57 serum uric acid 57 antiarrhythmic drugs 57 sonographic findings 57 olmesartan 57 predisposing factor 57 HGPIN 57 pulmonary dysfunction 57 histologic subtype 57 cranial irradiation 57 neurologic deficits 57 metachronous 57 APTIVUS r 57 chronic GVHD 57 chest radiographs 57 receiving ISENTRESS 57 Doxil ® 57 Ejection Fraction 57 abnormal heartbeats 57 antiarrhythmic 57 activator tPA 57 epithelial tumors 57 antiepileptic medications 57 placebo dexamethasone 57 ADPKD 57 hereditary predisposition 57 Severe acneform rash 57 primary aldosteronism 57 stent restenosis 57 latent celiac disease 57 coronary artery revascularization 57 RCTs 57 MMSE scores 57 hypomagnesemia 57 transfusion syndrome 57 myocardial ischaemia 57 Crohn Disease Activity 57 Infusion Reactions Severe 57 peri procedural 57 hyperhomocysteinemia 57 eptifibatide 57 INCB# [003] 57 ARB telmisartan 57 neurologic outcomes 57 thrombocytopenic patients 57 allogeneic HSCT 57 nodal metastases 57 T1c 57 nondiabetic 57 NOLVADEX 57 basal cell cancers 57 pulmonary thromboembolism 57 treatment emergent AEs 57 OPCAB 57 atrial tachyarrhythmias 57 HBV infections 57 BRCA1 mutations 57 acid suppressive medication 57 antithrombotic agents 57 bacteraemia 57 statin therapy 57 nephrotoxicity 57 rehospitalization 57 distant metastasis 57 TIA transient ischemic 57 elevated LDH 57 loop diuretic 57 arterial revascularization 57 COPD exacerbation 57 cerebrovascular diseases 57 FOLFOX4 57 invasive ductal 57 coronary stenoses 57 angiotensin receptor blockers 57 Peripheral edema 57 distant metastases 57 recurrent UTI 57 salmeterol fluticasone 57 pelvic lymphadenectomy 57 myocardial infarct 57 lymph node involvement 57 arrythmias 57 nocturnal hypoglycemia 57 clinically meaningful differences 57 spontaneous preterm birth 57 persistent pulmonary hypertension 57 GI bleeds 57 coronary disease 57 Subgroup analysis 57 citalopram Celexa 57 anticoagulants blood thinners 57 inflammatory lesions 57 XELOX 57 anemia hemoglobin 57 tibolone 57 dyslipidaemia 57 Subarachnoid hemorrhage 57 jaw ONJ 57 IGFD 57 adjunctive ABILIFY 57 argatroban 57 adjunctive placebo 57 rosuvastatin 57 metabolic abnormalities 57 bypass graft CABG surgery 57 occlusive disease 57 prospectively defined 57 atherothrombotic events 57 neoadjuvant 57 gallbladder disease 57 Hashimoto thyroiditis 57 cardiac troponin 57 pseudoaneurysms 57 virologic failures 57 Myocardial Infarction MI 57 nonalcoholic steatohepatitis NASH 57 pulmonary artery pressures 57 KIF6 carriers 57 confidence interval #.#-#.# 57 parkinsonian symptoms 57 ischemic cerebrovascular 57 cholecystitis 57 rofecoxib 57 isolated systolic hypertension 57 thromboembolic disease 57 irbesartan 57 liver metastasis 57 AVANDIA 57 abacavir 57 Taxus Stent 57 Barrett esophagus BE 57 metformin monotherapy 57 portal vein thrombosis 57 clot dissolving drug 57 reach statistical significance 57 atrial septal defects 57 affective psychoses 57 Baseline characteristics 57 nonresponders 57 PREZISTA r 57 CYPHER ® Stent 57 undergone radical prostatectomy 57 coronary vessels 57 de aths 57 atherothrombotic 57 Kaplan Meier curve 57 angina myocardial infarction 57 DVT PE 57 IIIa inhibitors 57 lung cancer NSCLC 57 serum sodium levels 57 hypercalcaemia 57 diagnostic angiography 57 perimenopausal women 57 coinfected 57 subclinical disease 57 Transient ischemic attacks 57 dronedarone 57 ketorolac 57 stent placement 57 atrial fibrillation AF 57 vasogenic edema 56 acute myocarditis 56 HbA1c levels 56 carcinoid 56 primary percutaneous coronary 56 serum triglycerides 56 gadolinium enhanced 56 nondepressed 56 HBeAg negative 56 myocardial infarction ventricular fibrillation 56 diastolic pressures 56 retransplantation 56 radial artery grafts 56 invasive coronary angiography 56 PROactive study 56 GIK infusion 56 bilateral TKA 56 heavily pretreated 56 HNSCC 56 multivariate adjustment 56 QTcF 56 pretest probability 56 thrombolytics 56 milrinone 56 statistically significant p = 56 atrioventricular valve 56 GI bleeding 56 Atypical antipsychotics 56 liver transaminases 56 contralateral breast cancer 56 evaluable subjects 56 receiving XGEVA 56 CYPHER R Sirolimus eluting 56 prolonged QT intervals 56 syncopal episode 56 incontinence episodes 56 lopinavir r arm 56 neovascular AMD 56 cardiovascular ischemic 56 severe asthma exacerbations 56 varices 56 Heavy menstrual bleeding 56 plus GP IIb 56 serum calcium 56 antihypertensive drugs 56 plain radiographs 56 ARIXTRA 56 tapentadol ER 56 postsurgical 56 papillary renal cell carcinoma 56 valvular heart disease 56 concomitant AEDs 56 hemodialysis patients 56 clopidogrel 56 prophylactic cranial irradiation 56 amiodarone 56 hepatocellular carcinomas 56 pioglitazone 56 Acute myocardial infarction